ALSO NOTED: French prefer Gardasil; Yellow fever cases spur demand for vaccinations; Juvaris testing adjuvant;and much more...

Vaccine Market

France's health authority is recommending Gardasil over Cervarix, a victory for a drug that has yet to be approved in the U.S. Report

Brazilians have been lining up for vaccinations after five people died from yellow fever. Report

Vietnam is distributing oral cholera vaccinations. Report

Canada has approved a new swine vaccine that was developed inside the country. Report

Lawmakers in Virginia are considering new legislation that would delay the mandatory vaccination of girls in the state with the new cervical cancer vaccine. Report

Vaccine Research

Juvaris will test JVRS-100 as an adjuvant to extend the use of existing H5N1 vaccine. Release

A researcher at the University of Iowa is making progress with his research into new  molecular approaches to develop vaccines, concentrating on purified proteins in place of the entire bacteria that would make vaccines simpler, easier to use and more effective. Release

Suggested Articles

The pandemic price could be lowered for larger deals, CEO Stephane Bancel said. Pfizer and BioNTech priced 100M doses at $19.50 each for the U.S.

Pfizer and BioNTech followed supply pacts in the U.S. and U.K. with a new deal to deliver 120 million vaccines to Japan in the first half of 2021.

Sanofi's cost cuts are adding up, execs said in an update Wednesday. The company has trimmed nearly €1 billion in annual expenses so far in 2020.